CRISPR Therapeutics AG (NASDAQ:CRSP)

45.48
Delayed Data
As of Sep 22
 -0.58 / -1.26%
Today’s Change
38.94
Today|||52-Week Range
72.00
+11.88%
Year-to-Date
CRISPR Therapeutics AG (CRSP) Stock Moves -1.07%: What You Should Know
Sep 21 / Zacks.com - Paid Partner Content
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
Sep 16 / MotleyFool.com - Paid Partner Content
$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years
Sep 21 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know
Sep 15 / Zacks.com - Paid Partner Content
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio
Sep 20 / MotleyFool.com - Paid Partner Content
Better Growth Stock: Recursion Pharmaceuticals vs. CRISPR Therapeutics
Sep 15 / MotleyFool.com - Paid Partner Content
Where Will CRISPR Therapeutics Be in 5 Years?
Sep 19 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks Defying the Bear Market
Sep 15 / MotleyFool.com - Paid Partner Content
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
Sep 19 / MotleyFool.com - Paid Partner Content
Better Bull Market Buy: CRISPR vs. Medtronic Stock
Sep 14 / MotleyFool.com - Paid Partner Content
Vertex (VRTX) Gets Positive CHMP Opinion for Kaftrio Expanded Use
Sep 18 / Zacks.com - Paid Partner Content
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
Sep 12 / MotleyFool.com - Paid Partner Content
2 Top Trends to Invest $500 In Right Now
Sep 18 / MotleyFool.com - Paid Partner Content
2 No-Brainer Biotech Stocks to Buy Right Now
Sep 12 / MotleyFool.com - Paid Partner Content
Looking for Growth? These Companies' Revenue May Skyrocket
Sep 17 / MotleyFool.com - Paid Partner Content